SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-120207
Filing Date
2020-04-27
Accepted
2020-04-27 07:32:33
Documents
5
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d889039ddefa14a.htm DEFA14A 22075
2 GRAPHIC g889039g25e99.jpg GRAPHIC 77126
3 GRAPHIC g889039g71q36.jpg GRAPHIC 33263
4 GRAPHIC g889039g76b12.jpg GRAPHIC 7054
5 GRAPHIC g889039g82k30.jpg GRAPHIC 93643
  Complete submission text file 0001193125-20-120207.txt   314147
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39114 | Film No.: 20817239
SIC: 2834 Pharmaceutical Preparations